Background: Biochemical diagnosis of adrenal insufficiency (AI) is difficult in the con-
| INTRODUC TION
Traumatic brain injury (TBI) is a major public health problem and the leading cause of disability among young adults. 1 The incidence of TBI in USA is 200 cases/year/100 000 head of population with 10%
requiring hospitalization and 1 in 3 of these patients being admitted to intensive care units. 2 A literature review of 23 reports from
Europe showed the overall incidence (range) of hospitalization for TBI to be 235(150-300)/100 000/year.
3
Few data are available for the African continent. In West Africa, road traffic accidents (RTA) are responsible for 80% of all head traumas in Nigeria alone, while more than half of deaths attributed to head injuries from RTA in Africa occur before patients can be admitted to hospital. 1 In Guinea, a study of 2829 victims of RTA during the year 2009 showed TBI to be present in 82% of cases with median age 27.1 years. 4 In East Africa, a study from Uganda showed TBI to be the second reason for admission to an intensive care unit, with 1774 patients admitted over 7 years.
5
In the Maghreb countries of North Africa, TBI accounted for 14 .4% of admissions in Tunisia, particularly in young adults, with a mortality rate of 29%.
6
The hypothalamic-pituitary adrenal axis is activated in response to the critical illness caused by TBI so that initially cortisol levels are increased. However, adrenocorticotrophic hormone (ACTH) deficiency can be caused by damage, necrosis and haemorrhage in the hypothalamus and pituitary. 7 Medications used for the management of the victims in the acute phase of brain injury can also induce modifications of cortisol metabolism. Moreover, critical illness may cause a resistance in cortisol action in different tissues caused by cytokine secretion. [7] [8] [9] The biochemical diagnosis of adrenal insufficiency (AI) is difficult in the context of critical illness such as TBI. 10 In particular, the cut-off for basal cortisol values which constitute AI remains controversial. In practice, it is neither feasible nor appropriate to carry out stimulation testing such as insulin tolerance test (ITT) to evaluate the corticotrope axis in critically ill patients with TBI while the corticotropin stimulation test using 250 μg may overestimate ACTH function. 9 Moreover, the cut-off for this test is not well established in critical illness.
7,8
It is nevertheless still important to evaluate basal cortisol in TBI despite the lack of consensual cut-offs. There is also a need to determine the predictive factors of AI in TBI as hydrocortisone treatment of truly deficient patients could improve their outcome. The aims of this study, therefore, were to determine the prevalence of AI in the acute phase of TBI according to defined serum cortisol cut-off in an unselected population; to determine what factors predicted low cortisol levels; and hence to develop an algorithm for clinical management. A further aim was to re-evaluate adrenal status during the recovery phase of TBI and hence determine the relationship between acute and subsequent AI. The clinical care of patients enrolled into the study was at the discretion of the attending critical care physicians and included the prescription of glucocorticoid in selected subjects. Dexamethasone was not given to the patients, in keeping with the evidence to show no benefit and increased mortality in TBI patients in whom steroids were given for intracerebral lesions.
| ME THODS

10
During the acute postinjury period (0-7 days), the measurement of serum cortisol was performed in all patients between 8 and 9 am on at least one occasion. Cortisol was assayed using the Cis-bio Adrenal insufficiency was defined using three cortisol cut-offs:
• 83 nmol/L; a value accepted as indicating severe adrenal deficiency.
11
• 276 nmol/L; a value indicating adrenal deficiency in critical illness according to the consensus statements from an international task force by the American College of Critical Care Medicine.
12
• 414 nmol/L; a value defined by Cohan et and recommended by
Hannon et al as indicating AI in victims of TBI.
13,14
The variables which were studied as potential associations with AI included age, severity of brain injury; duration of intubation and coma; pupillary status as anisocoria, mydriasis, isocoria; and ischaemic factors in terms of arterial hypotension (systolic and/or diastolic blood pressure <90 and 60 mm Hg) and anaemia (Hb < 9 g/dl). 
| RE SULTS
Between November 2009 and December 2013 a total of 277, Algerian patients with moderate or severe TBI were seen and their details are shown in Table 1 . There was a strong male predominance (93%) in the study population, age ranging from 18 to 65 years. RTA was the most frequent cause of brain injury, occurring in 48% of patients (M: 128, F: 4). Ninety-eight patients (35.5%) died (GOCS = 1) after a median hospital admission of 10.4 ± 11.6 days including 45 (45. 9%) deaths during the first week. However, half of the patients (n = 140) had a good outcome with GOCS 5.
| Data relating to neurological status during acute phase of TBI
Of the 277 patients, 144 (48%) had moderate and 133(52%)
severe TBI according to GCS, and 177 (63.8%) were intubated for a mean period of 7.2 ± 11 days. Mean duration of coma was 
| Cortisol data during the acute phase of TBI
A single cortisol sample was taken during the acute phase ( Figure 1) of TBI from all 277 patients with a median (range) time at sampling of 3 (1-7). Analysis using one-way ANOVA showed no significant Table 2 shows the bivariate analysis comparing the patients with and without post-traumatic AI according to the three chosen cut-off levels of cortisol. No association could be found between the three cortisol cutoffs and severity of TBI according to GCS or pupillary status. However, the presence of intraparenchymal haematoma was predictive of AI for all three cortisol cut-offs. Diastolic blood pressure <60 mm Hg was associated with AI for the 83 and 276 but not the 414 nmol/L cut-offs.
| Factors associated with low cortisol cut-offs during acute phase of TBI
There was no significant association between anaemia and AI but acute insipidus diabetes was associated with AI at the 414 nmol/L cut-off level.
The prescription of Pentothal and Propofol in sedated patients was associated with cortisol level <83 nmol/L, indicating a strong correlation (P: .00004-P: .022). These findings were not found for the other agents.
Multiple extracranial injuries and cranial surgery were not associated with post-traumatic AI. Mortality was not significantly associated with AI for the three cortisol cut-offs. However, the highest mortality was seen in patients with acute cortisol <276 nmol/L (44.6% with OR for death of 1.64, 95% CI 0.92-3.0, P = .12). Receiver operator curve analysis showed no meaningful correlation between acute cortisol and the response to ITT 3 months later indicating that no acute cortisol cut-off was of predictive value.
| Adrenal axis function during the recovery phase of TBI
| Pituitary function during recovery phase
The overall prevalence of post-traumatic hypopituitarism 3 months after injury was 44% with corticotrophin deficiency in 39 (29, 3%) patients; growth hormone deficiency in 24 (18%); gonadotrophin deficiency in 9 (6.8%); hypoprolactinaemia in 9 (6.8%); hyperprolactinaemia in 5 (3.8%); and thyrotropin deficiency in 2 (1.5%).
| D ISCUSS I ON
Traumatic brain injury is an important public health problem and remains the leading cause of handicap and disability in young adults. to increased mortality. 19 Increased secretion due to activation of the corticotrophin axis, mediated by hypothalamic CRF secretion in response to stress, 8, 9 is one explanation for this finding. Another proposed mechanism is cortisol resistance in target tissues, caused by the increased cytokine secretion which occurs in response to brain injury. 8, 9 The use of medication in the acute phase of TBI may also modify cortisol metabolism both by inhibiting steroidogenesis and by acting as enzymatic inducers.
8,13
Cortisol levels of <83-138 nmol/L during the acute phase of TBI clearly demonstrate an impaired response of the adrenal axis to stress and indicate AI. However, values >138 nmol/L cannot exclude the possibility of AI especially in critical illness; indeed the appropriate cut-off level defining AI is still not established. CorƟsol nmol/L Days TA B L E 2 Bivariate analysis of factors predicting adrenal insufficiency (AI) using three chosen cortisol cut-offs: 83, 276 and 414 nmol/L. Significance for differences was set at P values <.05. Glasgow outcome coma score (GOCS) of 1 equates to mortality, and GOCS2-3-4-5 refers to surviving patients study in which 80 victims were compared with a control group. 13 Hannon et al recommended the same cut-off level for defining posttraumatic AI. 14 Mean cortisol in our sample of patients was 573.1 ± 376.2 nmol/L and is in keeping with other studies. 13, 20, 21 Lower values were reported by authors who evaluated cortisol levels in TBI victims without prior exclusion of patients receiving glucocorticoids.
22,23
In the present study, the prevalence for the lowest cortisol cutoff level of 83 nmol/L was 2.9%, almost identical with the prevalence reported in other studies. 19, 24, 25 For the middle cortisol cut-off of 276 nmol/L, the prevalence of AI was 20.2% in our study, contrasting with the higher figures of 54% and 70% prevalence values reported by Olivecrona et al on the first and fourth post-TBI days 26 and the lower prevalence of 9.8%
reported by Tanriverdi et al. 21 These discrepancies are at least partly explained by variation in the severity of TBI in the different studies. Not retested in recovery phase n = 12
Not retested in recovery phase n = 30
Hannon et al studied 100 TBI victims aged 18-75 years with GCS <14 and compared them with 50 controls, measuring cortisol at admission and during the ten consecutive days. Cortisol levels in controls were >500 nmol/L whereas 78% of injured patients had values <300 nmol/L on the first day which was still low in 63% patients on the 3rd day. Cortisol levels increased thereafter at the 10 days after injury in 41 of patients (61.5%).
27
As shown in Table 3 , some authors have evaluated the corticotrophin axis using dynamic tests and shown a degree of AI in 4%-24% of cases, depending on the time of testing, the populations studied and the severity of TBI.
In our study, re-evaluation of adrenal status was carried out in nearly three-quarters of surviving patients. AI was found in all Ischaemic factors such as anaemia, hypoxia and hypotension are known to cause pituitary damage in Sheehan's syndrome. 7, 8 In this study, we found that diastolic hypotension but not anaemia was predictive of acute post-traumatic AI. Similarly, Cohan et al found a positive correlation between AI and mean blood pressure of <60 mm Hg but not for hypoxia and anaemia. Phenobarbital is an enzymatic inducer. In situations where these agents interfere with the corticotrophin axis, the challenge is to distinguish between medication-induced or organic post-traumatic AI as this will affect the need and the duration for steroid treatment.
For this reason, Cohan et al recommend monitoring cortisol levels in intubated patients with traumatic head injury, particularly those receiving high dose of Pentobarbital or Propofol.
13
Polytrauma was studied as a risk factor for AI in our series given its potential effect on haemodynamic status which could in turn result in pituitary necrosis. However, neither this factor nor cranial surgery could not be shown to affect the prevalence of post-traumatic AI.
The frequency of post-traumatic diabetes insipidus was 2.8% in our study, consistent with the 2.9% prevalence reported by Boughey et al. 33 This contrasts markedly to the very high figure of 26% in 50 TBI victims described by Agha et al and may be explained by the high proportion of patients with severe injury (64%) in that study. In the present study, the presence of DI was correlated with acute AI for cortisol levels less than of 414 nmol/L, the putative mechanism being ischaemic or haemorrhagic insult to the posterior and anterior pituitary causing both DI and corticotrophin deficiency.
All the patients with DI in our study had severe brain injury with GCS <8 and all died.
An association between acute post-traumatic AI and mortality could not be shown in our study, in keeping with the work of Della Corte et al and Olivecrona et al 26, 28 and in contrast to
Hannon et al. 14 Nor could we confirm the work of Kakatti et al who showed a correlation between elevated cortisol levels of >23 μg/dL (634 nmol/L) and increased mortality. 19 Nevertheless, the higher mortality seen in those of our patients with acute cortisol <276 nmol/L has influenced our recommendations for clinical care as shown below. In patients with AI risk factors such as diastolic hypotension, intraparenchymal haematoma, diabetes insipidus, skull base fracture and the prescription of sedatives such as Pentothal and Propofol, we recommend immediate cortisol sampling. This should be followed by hydrocortisone cover in those patients with cortisol <276 nmol/L given that mortality was higher in such patients. We also advise cortisol cover in patients with cortisol <414 nmol/L in whom AI risk factors persist given the Cohan recommendations 13,14 and recognising that cortisol values of <500 nmol/L in stressed patients with TBI are relatively low. 19 The rationale for choosing the <414 nmol/L in patients with no AI risk factors, a serum cortisol should be taken during the first week. Given the poor correlation between acute and subsequent AI, and the significant incidence of hypopituitarism shown in this study 3 months after TBI, we recommend pituitary re-evaluation in all patients with moderate and severe TBI during the recovery period, irrespective of adrenal status during the acute phase.
ACK N OWLED G M ENTS
The authors thank the doctors and the nurses of neurosurgery and critical care medicine departments of Salim Zemirli hospital and central hospital of army in Algiers. We also thank the patients and their families'. We thank Professor A.M. Aouni and Doctor I. Ararem for their statistical help. We thank Professor Tim Cole for statistical guidance.
O RCI D
Meriem Bensalah
http://orcid.org/0000-0002-5787-6076
R E FE R E N C E S
